medical-device-investing Viveve Submits Investigational Device Exemption to FDA to Conduct LIBERATE-U.S. Trial for Improvement of Stress Urinary Incontinence
Inspire Medical Systems Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
medical-device-investing ChroMedX Reports on HemoPalm Techno-Commercial Analysis and Productization Plan
UTHealth in Houston and Athersys Announce Funding for Clinical Trial using MultiStem® to Treat Trauma Patients
medical-device-investing Inspire Medical Systems Announces Filing of Registration Statement for Proposed Initial Public Offering
medical-device-investing ChroMedX CEO Lahav Gil Invited to Speak on Industry Panel at bioTEC, Biotechnology and Bioengineering Conference
medical-device-investing ChroMedX Accelerates Software Development and Implementation Activities; Appoints iGAL Roytblat, Formerly of Kangaroo Group, as CTO, Amid Expansion
medical-device-investing iCAD Granted CE Mark Approval in Europe for PowerLook Tomo Detection 2.0 Artificial Intelligence Solution
medical-device-investing SeaSpine Announces Fourth Quarter and Full-Year 2017 Results and Issues 2018 Financial Guidance
